Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.
The invention relates to pyridone amide compounds of formula I and I′ or pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels:
The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders, including pain.
Pyrimidine compounds of formula (1):
1
wherein R
1
is C
3
-C
7
alkynyl optionally substituted with halogen; R
2
and R
3
are independently hydrogen or the like; and R
4
is C
3
-C
7
alkynyloxy optionally substituted with halogen, optionally substituted phenyl, or the like have an excellent pesticidal effect.
Anilinopyrazole derivatives useful for the treatment of diabetes
申请人:Rudolph Joachim
公开号:US20080064734A1
公开(公告)日:2008-03-13
The present invention relates to anilinopyrazole compounds, pharmaceutical compositions, and methods for treating diabetes and related disorders.
本发明涉及苯胺吡唑化合物,制药组合物以及治疗糖尿病及相关疾病的方法。
Modulators of ATP-binding cassette transporters
申请人:Ruah Sara S. Hadida
公开号:US20080113985A1
公开(公告)日:2008-05-15
Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.